Use of LIMK-1, its analogues and ligands for the production of a medicament against a thrombus formation or blood clotting disease

Details for Australian Patent Application No. 2004294263 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Leeuw, Thomas; Sibenhorn, Gertrud; Rueck, Alexander; Herrmann, Matthias

Agent Watermark

Pub. Number AU-A-2004294263

PCT Pub. Number WO2005/053734

Priority 03027839.4 04.12.03 EP

Filing date 23 November 2004

Wipo publication date 16 June 2005

International Classifications

A61K 38/45 (2006.01) Medicinal preparations containing peptides

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/053734 Priority application(s): WO2005/053734

11 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294266-Method of treating a patient's teeth using fluoride releasing glass composition

2004294259-Active substance combination having insecticidal and acaricidal properties